Article Review – A Clear Guide to PCa Biomarkers
DISCLAIMER: AnCan does not endorse Superpower or any of its products. All patients should discuss with their healthcare provider before using any of their products or any of the tests or advice in the article.
In another of the seemingly endless organizations offering premium health services, Superpower, founded in 2023, provides a fairly straightforward overview of the myriad tests and biomarkers available to Prostate Cancer patients (https://superpower.com/cancer-biomarkers/prostate-cancer?msID=a298d71f-c6af-478d-aa4b-f8279edb34c4). Seasoned AnCaners may find little new in here, especially those that attend or review many of the recent seminars/webcasts, but newcomers or those needing a refresher may find it helpful for further research or equipping you to be your own best advocate. The article hits many of the main tests with which we are all familiar, as well as some of the urine biomarkers (PCA3, Select MDx, ExoDX), without specifically endorsing any of them. It does touch on MRIs, but only multi-parametric, not bi-parametric MRIs, nor does it get into the trans-rectal versus trans-perineal debate. Be forewarned, there is information with which not everyone will agree (shocking, I know), but it is still a useful, albeit somewhat rudimentary tool.